Top Analyst Upgrades and Downgrades: Allergan, Galmed, GM, Sirius XM, SunPower and More

Photo of Jon C. Ogg
By Jon C. Ogg Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Stocks have recovered and are yet again within striking distance of new all-time highs. With earnings season is in full swing, investors want the strong upside stocks but want to avoid the traps and pitfalls that are waiting to wreck their portfolios. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week for new ideas. Some of these analyst reports cover stocks to buy, while some cover stocks to sell or to avoid. These are this Wednesday’s top analyst upgrades, downgrades and initiations.

Allergan Inc. (NYSE: AGN) was raised to Overweight with a $190 price target by J.P. Morgan.

A.O. Smith Corp. (NYSE: AOS) saw several hikes after the earnings report: BMO Capital Markets raised it to Outperform, Wedbush raised it to Outperform and Sterne Agee raised it to Buy.

Boston Scientific Co. (NYSE: BSX) was reiterated as Outperform and the price target was raised to $15 from $14 at RBC Capital Markets.

E*Trade Financial Corp. (NASDAQ: ETFC) was raised to Outperform at Wells Fargo.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) was started as Buy and with a $24 price target (versus a $9.15 close) by Maxim Group.

ALSO READ: UBS Top Stocks to Buy Working for Cancer Cures

General Motors Co. (NYSE: GM) was reiterated as Buy with a $43 price target by Bank of America Merrill Lynch.

Illumina Inc. (NASDAQ: ILMN) had strong earnings and was reiterated as Buy with a $195 target at Merrill Lynch. Mizuho also reiterated its Buy rating and raised the target to $200.

Sirius XM Holdings Inc. (NASDAQ: SIRI) was maintained as Hold at Wunderlich, but the firm trimmed the price target to $3.50 from $3.80.

SunPower Corp. (NASDAQ: SPWR) was raised to Buy from Neutral with a $37 price target at Merrill Lynch.

Vitamin Shoppe Inc. (NYSE: VSI) was raised to Buy and given a $57 price target (versus a $47.89 close) at Sterne Agee.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618